SCIEGEN PHARMS INC FDA Approval ANDA 211232

ANDA 211232

SCIEGEN PHARMS INC

FDA Drug Application

Application #211232

Application Sponsors

ANDA 211232SCIEGEN PHARMS INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL25MG0ETHACRYNIC ACIDETHACRYNIC ACID

FDA Submissions

UNKNOWN; ORIG1AP2019-08-27STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

SCIEGEN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211232
            [companyName] => SCIEGEN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ETHACRYNIC ACID","activeIngredients":"ETHACRYNIC ACID","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/27\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-08-27
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.